In a cross-sectional study including 84 Brazilian obese patients with T2DM and biopsy-proven NAFLD, Leite et al. reported that plasma adiponectin levels were lower in patients with NASH than in their counterparts without NASH [18]. This evidence concerns the gene ADIPOQ and metabolic dysfunction-associated steatotic liver disease.